Journal for ImmunoTherapy of Cancer (Nov 2023)
1246 Immune related adverse events to checkpoint inhibitors are associated with altered regulatory T cell phenotypes and resemble CTLA4-deficient patients
Abstract
No abstracts available.
Journal for ImmunoTherapy of Cancer (Nov 2023)